References
- Sundhedsstyrelsen, September 2015. Diabetes. Chapter 9. Available at: https://www.sundhedsstyrelsen.dk/da/sundhed/folkesygdomme/diabetes
- Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. N Engl J Med 2012;366:1319-27
- Cahn A, Miccoli R, Dardano A, et al. New forms of insulin and insulin therapies for the treatment of type 2 diabetes. Lancet Diabetes Endocrinol 2015;3:638-52
- Blak BT, Smith HT, Hards M, et al. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin. Diabet Med 2012;29:e13-20
- Qualitative and Quantitative Fieldwork Services (QQFS), J A Wettergrens gata 5, 421 30 Västra Frölunda, Gothenburg, Sweden. Available at: http://www.qqfs.com
- Cohen SH. Maximum Difference Scaling: Improved Measures of Importance and Preference for Segmentation. Sawtooth Software research paper series. 2003
- Jensen MM, Pedersen-Bjergaard U. Self-reported frequency and impact of non-severe hypoglycemic events in insulin-treated diabetic patients in Denmark. Diabetes Manag 2015;5:67-78
- AACE. American Association of Clinical Endocrinologists Diabetes Guidelines. 2013. Available at: https://www.aace.com/publications/algorithm
- American Diabetes Association (ADA). Standards of Medical Care in Diabetes. 2014. Available at: http://care.diabetesjournals.org/content/37/Supplement_1/S14.extract
- Thomsen RW, Baggesen LM, Sogaard M, et al. Early glycemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes. Diabetologia 2015;58:2247-53
- Kenny C, Hall G. GLP-1 receptor agonist and basal insulin co-therapy in type 2 diabetes: clinical evidence and practicalities of use. Diabetes Primary Care 2015;17:80-5
- Khunti K, Nikolajsen A, Thorsted BL, et al. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab 2016;18:401-9
- Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc 2016;91:1231-55
- Luijks H, Schermer T, Bor H, et al. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med 2012;10:128
- The Danish College of General Practitioners (DSAM) and the Danish Endocrine Society (DES). Guidelines for type 2-diabetes, 2014 revision. Farmakologisk behandling af type 2-diabetes. Available at: http://www.dsam.dk/files/11/farmakologisk_behandling_af_type_2_rev_2014.pdf
- Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centred approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:1577-96
- Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005;294:716-24
- Bound J. Self-reported versus objective measures of health in retirement models. J Hum Resour 1991;26:106-38
- Anderson KH, Burkhauser RV. The importance of the measure of health in empirical estimates of the labour supply of older men. Econ Lett 1984;16:375-80
- Brutus S, Aguinis H, Wassler U. Self-reported limitations and future directions in scholarly reports: analysis and recommendations. J Manage 2013;39:48-75
- Hanson R. Determining attribute importance: Quirk’s marketing research review. 1992. Available at: http://www.quirks.com/articles/article.asp?arg_articleid=430
- Jaccard J, King G. The relation between behavioral intentions and beliefs: a probabilistic model. Hum Commun Res 1977;3:326-34